Company news

Hua Medicine Ltd. news in 2020

Hua Medicine Ltd.'s news releases, calls and decks from 2020, newest first.

View company

Hua Medicine: Successfully Completes Its Registration Phase III Trials; Announces 52-Week Results for DAWN (HMM0302), Dorzagliatin's Phase III Combination with Metformin Trial

December 17, 2020